Healthcare-associated Infectious Disease Diagnostics Market By Infection Type (Urinary Tract Infections, Surgical Site Infections, Hospital-acquired Pneumonia, Blood Stream Infections, Gastrointestinal Infections, and Other Healthcare-associated Infections), By Product Type (Consumables and Analyzers/Instruments), By Test Type (Traditional Diagnostics and Molecular Diagnostics), By End-User Type (Hospitals, Clinics, ASCs, and Others), and By Region - Trends, Analysis and Forecast till 2030

The rise of the worldwide market for infectious disease diagnostics related to healthcare is primarily driven by the high prevalence and rising incidence of contagious diseases. Other significant factors that are anticipated to fuel the target market's growth throughout the forecast period include rising government initiatives for the development of adequate healthcare infrastructure in developing nations, technological advancements in diagnostic equipment, and high levels of awareness regarding disease diagnostics in developed economies. However, two key issues impeding the global market's growth are rising healthcare expenses in prosperous economies and a need for more understanding regarding the detection of infectious diseases in emerging economies.

Furthermore, another significant factor expected to restrict the global market's growth over the projection period is the absence of appropriate reimbursement policies in established markets and in some emerging economies. However, the primary and growing trend for worldwide market growth is the increasing adoption of technologically improved visual diagnostic equipment in healthcare facilities in developing nations. This is another aspect that is anticipated to support the global market's rise in the upcoming years.